Abstract: There is provided an elastomer optimization method of a six-dimensional force sensor, which belongs to the field of structure optimization. This method solves the problems of low optimization efficiency and ease of occurrence of non-convergence in the existing elastomer structure optimization method of the six-dimensional force sensor. In the method of the present disclosure, the finite element analysis and the mathematical calculation are combined to screen the main structure parameter variables affecting the condition number and obtain the optimal elastomer safety coefficient fitting function, the optimal elastomer mass fitting function and the optimal condition number fitting function.

Abstract: There is provided a whole-plane six-dimensional force sensor elastomer, which relates to the field of six-dimensional force sensor elastomers. The present disclosure aims to solve the problem of inability of the existing six-dimensional force sensor elastomers to maintain large bearing capacity while having small size and light weight. The elastomer of the present disclosure includes an outer ring and an inner ring. The outer ring is sleeved on an outer side of the inner ring, and four beam assemblies are disposed and connected between the outer ring and the inner ring. The four beam assemblies are equidistantly disposed circumferentially between the outer ring and the inner ring. An end of each beam assembly is disposed integrally with the outer ring and the other end of each beam assembly is disposed integrally with the inner ring. One strain measurement unit assembly is mounted on each beam assembly.

Abstract: A compound represented by general formula (I) or stereoisomers thereof and pharmaceutically acceptable salts, solvates or prodrugs thereof, a preparation method therefor and a pharmaceutical composition containing the compound. An application of the compound of general formula (I) in preparation of drugs for treating and/or preventing she-mediated diseases, especially an application in preparation of drugs for treating inflammatory diseases, cardiovascular and cerebrovascular diseases, diabetes, diabetes complications, diabetes-related diseases, fibrotic diseases, neurological and mental diseases, pain, and ulcer diseases, etc.

Abstract: Electricity retail trading systems and methods for coupling a wholesale market are disclosed. In some embodiments, an electricity retail trading system includes a user login module, a trade unit management module, a first display module, a wholesale market trade module, a retail preliminary distribution module, a data acquisition and deviation calculation module, a second display module, a deviation transfer trade module, a third display module, a retail final distribution module, and a fourth display module. In other embodiments, an electricity retail trading method includes the following steps: (a) user login, (b) trade unit management, (c) declaration and clearing of wholesale market trade, (d) retail preliminary distribution of electricity retailer, (e) data acquisition and deviation quantity calculation, (f) declaration and clearing of deviation transfer market trade, and (g) retail final distribution of electricity retailer.